I believe that the flurry of selling near the close was probably some folks selling in anticipation that earnings will be bad...which they probably will be. For those who invest for periods measured in months or years, however, it's not the earnings that are important at this time. I'm much more interested in what is said on the conference call. What we need is evidence that the test is beginning to be accepted by doctors, patients, and insurance companies. Tomorrow will be interesting, and probably volatile.
Looking at Intertanko, I notice that for virtually all tanker types, rates are holding up very well. Compared to last year they are all in the ballpark of $10K per day higher in '15 than '14, except for VLCCs which are way higher.
Just google "Blue Fighter" and you'll find that it's coming and going from the port "Peterhead" about once or twice per day. Don't know who it's booked for.
Blue Viking: CNR UK / SUPPLY DUTIES, D/D 28
It looks like the fleet is being well utilized. This should lead to continued good dividends.
This is a quiet board. But, I believe that this company is set to show rapid growth of earnings and dividends in 2015. Strong rental market and rising home prices should help boost profits. Book value over $28. I expect good earnings and an upbeat call.
My guess is that the shorts are younger guys who have never had to do the prep for a colonoscopy. I've been there and will avoid ever doing it again, if possible. I'll gladly do three cologuard tests to avoid one colonoscopy.
Depends on what you're looking for. If you own it for the decent, and slowly growing, dividend, it's a good stock to hold. If you're looking for significant near term appreciation, you'll probably be disappointed. The recent performance probably won't continue. Overall, it looks to me like one of the safer places to get around a 5% return.
I wouldn't expect a secondary that soon unless they find a bargain that they want to invest in. They are taking in a lot of cash right now and should be able to cover their recent investments with cash flow, and if not, will have no trouble borrowing at good rates. No need to sell more stock at current prices.